Kalaris Therapeutics, Inc. · NASDAQ:KLRS
Invus Public Equities, L.P.'s stake in Kalaris Therapeutics, Inc. fell to 1.50% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 29, 2025
Invus Public Equities, L.P.'s stake in Kalaris Therapeutics, Inc. fell to 1.50%, 282,586 shares, as a passive investor on Jun 30, 2025. Filed Jul 29, 2025 (Schedule 13G/A).
- Stake
- 1.50%
- Shares
- 282,586
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Invus Public Equities, L.P. | 1.50% | 282,586 |
| Invus Public Equities Advisors, LLC | 1.50% | 282,586 |
| Invus Global Management, LLC | 1.50% | 282,586 |
| Siren, L.L.C. | 1.50% | 282,586 |
| Raymond Debbane | 1.50% | 282,586 |
Source
Related
- Kalaris Therapeutics, Inc.
- Invus Public Equities, L.P.
- Kalaris Therapeutics, Inc. shareholders
- Form 4 · Srinivas Akkaraju · May 22, 2026
- Schedule 13D/A · Akkaraju Srinivas · May 22, 2026
- Schedule 13G · Rtw Investments, LP · Feb 17, 2026
- Schedule 13D/A · Akkaraju Srinivas · Feb 17, 2026
- Schedule 13D/A · Akkaraju Srinivas · Dec 22, 2025